CoChat
Sign Up
Cited by 874Nerve injury and regenerationAlzheimer's disease research and treatmentsNuclear Receptors and Signaling

The DOI matches its Crossref record; 550 of the 550 references it cites were found in a registry or an index.

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease

Murer, M.G, Yan, Q, Raisman-Vozari, R·2001·Progress in Neurobiology
DOI 10.1016/s0301-0082(00)00014-9
Open this paper in CoChat — free account

Abstract

Brain-derived neurotrophic factor (BDNF) is a small dimeric protein, structurally related to nerve growth factor, which is abundantly and widely expressed in the adult mammalian brain. BDNF has been found to promote survival of all major neuronal types affected in Alzheimer's disease and Parkinson's disease, like hippocampal and neocortical neurons, cholinergic septal and basal forebrain neurons, and nigral dopaminergic neurons. In this article, we summarize recent work on the molecular and cellular biology of BDNF, including current ideas about its intracellular trafficking, regulated synthesis and release, and actions at the synaptic level, which have considerably expanded our conception of BDNF actions in the central nervous system. But our primary aim is to review the literature regarding BDNF distribution in the human brain, and the modifications of BDNF expression which occur in the brain of individuals with Alzheimer's disease and Parkinson's disease. Our knowledge concerning BDNF actions on the neuronal populations affected in these pathological states is also reviewed, with an aim at understanding its pathogenic and pathophysiological relevance.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0301-0082(00)00014-9

Cites

550 of 550 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Items 201–400 of 550

Research works printed but not linked: 5

  1. Beck, 1992, Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-phenyl-pyridinium, Neurodegeneration, 1, 27
  2. Engele, 1998, Changing responsiveness of developing midbrain dopaminergic neurons for extracelular growth factors, J. Neurosci. Res., 51, 508, 10.1002/(SICI)1097-4547(19980215)51:4<508::AID-JNR10>3.0.CO;2-# · DOI
  3. Griesbeck, 1999, Are there differences between the secretion characteristics of NGF and BDNF? Implications for the modulatory role of neurotrophins in activity-dependent neuronal plasticity, Microsc. Res. Tech., 45, 262, 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K · DOI
  4. Hirsch, 1992, Expression of calbindin D28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: normal distribution and distribution in Parkinson’s disease, Neurodegeneration, 1, 83
  5. Kiprianova, 1999, Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat, J. Neurosci. Res., 56, 21, 10.1002/(SICI)1097-4547(19990401)56:1<21::AID-JNR3>3.0.CO;2-Q · DOI

Cited by

Sorted by citations

See all 874

Related

See all

Metadata

Authors
Murer, M. G., Yan, Q., & Raisman-Vozari, R.
Affiliations
  • Universidad de Buenos Aires (AR)
  • Amgen (United States) (US)
Corresponding author
Murer, M.G
ORCID
Murer, M.G
Venue
Progress in Neurobiology
Publisher
Elsevier BV
Published
2001-01
Volume
63
Issue
1
Pages
71-124
ISSN
0301-0082 (ISSN-L)
DOI
10.1016/s0301-0082(00)00014-9
OpenAlex
W2063849763
Cited by
874
References
550
Citations by year
2026: 15 · 2025: 16 · 2024: 26 · 2023: 34 · 2022: 29 · 2021: 36 · 2020: 44 · 2019: 45 · 2018: 27 · 2017: 39 · 2016: 52 · 2015: 40 · 2014: 42 · 2013: 52 · 2012: 45
FWCI
2.22
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Progress in Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
brain-derived neurotrophic factor, Alzheimer's disease, Parkinson's disease, neurotrophins, nerve growth factor, intracellular trafficking, neuronal survival, dopaminergic neurons, cholinergic neurons, hippocampal neurons, neurodegeneration
MeSH terms
Alzheimer Disease, Brain, Humans, Parkinson Disease, Reference Values, Tissue Distribution, Brain-Derived Neurotrophic Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review